Clinical Trials Directory

Trials / Completed

CompletedNCT00947024

To Demonstrate the Effect of Food on the Bioavailability of Glipizide

The Effect of Food on the Bioavailability of Glipizide

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Sandoz · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To demonstrate the effect of food on the bioavailability of Glipizide.

Conditions

Interventions

TypeNameDescription
DRUG10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.
DRUG10 mg Glucotrol Tablet (Roerig), Administered Immediately After a Standard Breakfast.
DRUG10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered After an Overnight Fast.

Timeline

Start date
1993-11-01
Primary completion
1993-11-01
Completion
1993-11-01
First posted
2009-07-27
Last updated
2017-03-28

Source: ClinicalTrials.gov record NCT00947024. Inclusion in this directory is not an endorsement.